Last reviewed · How we verify

NCT05029362

SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups

Completed NA Results posted Last updated 20 July 2025
What this trial tests

NA trial testing SmokefreeSGM in Smoking Cessation in 18 participants. Completed in 5 October 2022.

Timeline
5 January 2022
Primary endpoint
5 October 2022
5 October 2022

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment18
Start date5 January 2022
Primary completion5 October 2022
Estimated completion5 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Perceived Usability as Assessed by the System Usability Scale (SUS) Primary · 1 month after quit date

The 10-item System Usability Scale (SUS) was used to assess the usability of the SmokefreeSGM text messaging program. Total score ranges from 0 to 100, with a higher score indicating greater acceptability and a score above 75 indicating that the program is perceived as acceptable.

GroupValue95% CI
Beta Testing Group81.67± 15.46
Engagement as Assessed by the Number of Text Messages Sent and Received by Study Participants After Enrollment. Secondary · 1 month after enrollment

A participant's engagement rate was determined by dividing the total number of participant responses to the bidirectional text messages (numerator) by the total number of bidirectional text messages sent by the text-based platform (denominator). Participants who had rates ≤33.3% were classified as having low engagement, 33.3-66.6% moderate engagement, and ≥66.7% high engagement. Data are reported categorically as number of participants who have low, moderate, or high engagement.

Low engagement
GroupValue95% CI
Beta Testing Group5
moderate engagement
GroupValue95% CI
Beta Testing Group3
high engagement
GroupValue95% CI
Beta Testing Group10

Sponsor's own description

The purpose of this study is to pretest the design of a text-based smoking cessation program tailored to sexual minority individuals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Text-Based Smoking Cessation Intervention for Sexual and Gender Minority Groups: Protocol for a Feasibility Trial.
    Tami-Maury I, Klaff R, Hussin A, Smith NG, et al · · 2022 · cited 7× · PMID 36485022 · DOI 10.2196/42553

Verify or expand the search:

Other trials of SmokefreeSGM

Trials testing the same drug.

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05029362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing